JPWO2020190774A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020190774A5
JPWO2020190774A5 JP2021555405A JP2021555405A JPWO2020190774A5 JP WO2020190774 A5 JPWO2020190774 A5 JP WO2020190774A5 JP 2021555405 A JP2021555405 A JP 2021555405A JP 2021555405 A JP2021555405 A JP 2021555405A JP WO2020190774 A5 JPWO2020190774 A5 JP WO2020190774A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylenyl
haloalkyl
halogen
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021555405A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525186A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/022757 external-priority patent/WO2020190774A1/en
Publication of JP2022525186A publication Critical patent/JP2022525186A/ja
Priority to JP2023076091A priority Critical patent/JP2023113615A/ja
Publication of JPWO2020190774A5 publication Critical patent/JPWO2020190774A5/ja
Pending legal-status Critical Current

Links

Images

JP2021555405A 2019-03-15 2020-03-13 Ｔｅａｄ転写因子新規小分子阻害剤 Pending JP2022525186A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023076091A JP2023113615A (ja) 2019-03-15 2023-05-02 Ｔｅａｄ転写因子の新規小分子阻害剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962819347P 2019-03-15 2019-03-15
US62/819,347 2019-03-15
PCT/US2020/022757 WO2020190774A1 (en) 2019-03-15 2020-03-13 Novel small molecule inhibitors of tead transcription factors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023076091A Division JP2023113615A (ja) 2019-03-15 2023-05-02 Ｔｅａｄ転写因子の新規小分子阻害剤

Publications (2)

Publication Number Publication Date
JP2022525186A JP2022525186A (ja) 2022-05-11
JPWO2020190774A5 true JPWO2020190774A5 (el) 2023-05-22

Family

ID=72520559

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021555405A Pending JP2022525186A (ja) 2019-03-15 2020-03-13 Ｔｅａｄ転写因子新規小分子阻害剤
JP2023076091A Pending JP2023113615A (ja) 2019-03-15 2023-05-02 Ｔｅａｄ転写因子の新規小分子阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023076091A Pending JP2023113615A (ja) 2019-03-15 2023-05-02 Ｔｅａｄ転写因子の新規小分子阻害剤

Country Status (12)

Country Link
US (1) US20230113085A1 (el)
EP (1) EP3937943A4 (el)
JP (2) JP2022525186A (el)
KR (1) KR20210143803A (el)
CN (1) CN113811300A (el)
AU (1) AU2020241258A1 (el)
BR (1) BR112021018303A2 (el)
CA (1) CA3133753A1 (el)
IL (1) IL286352A (el)
MA (1) MA55322A (el)
MX (1) MX2021011209A (el)
WO (1) WO2020190774A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY37806A (es) 2017-07-11 2020-01-31 Vertex Pharma Carboxamidas como moduladores de los canales de sodio
US11458149B1 (en) 2019-05-31 2022-10-04 Ikena Oncology, Inc. TEAD inhibitors and uses thereof
JP2022534426A (ja) 2019-05-31 2022-07-29 イケナ オンコロジー， インコーポレイテッド Ｔｅａｄ阻害剤およびその使用
US11787775B2 (en) 2020-07-24 2023-10-17 Genentech, Inc. Therapeutic compounds and methods of use
WO2022120353A1 (en) * 2020-12-02 2022-06-09 Ikena Oncology, Inc. Tead inhibitors and uses thereof
WO2022120355A1 (en) 2020-12-02 2022-06-09 Ikena Oncology, Inc. Tead degraders and uses thereof
KR20230149885A (ko) 2021-01-25 2023-10-27 이케나 온콜로지, 인코포레이티드 폐암 치료에 사용하기 위한 3-(이미다졸-4-일)-4-(아미노)-벤젠설폰아마이드 tead 저해제와 egfr 저해제 및/또는 mek 저해제의 조합
EP4323066A1 (en) 2021-04-16 2024-02-21 Ikena Oncology, Inc. Mek inhibitors and uses thereof
WO2023060227A1 (en) 2021-10-07 2023-04-13 Ikena Oncology, Inc. Tead inhibitors and uses thereof
WO2023122781A2 (en) * 2021-12-23 2023-06-29 The Katholieke Universiteit Leuven Tetrahydrobenzoazepinones and related analogs for inhibiting yap/taz-tead
WO2023173057A1 (en) 2022-03-10 2023-09-14 Ikena Oncology, Inc. Mek inhibitors and uses thereof
WO2023173053A1 (en) 2022-03-10 2023-09-14 Ikena Oncology, Inc. Mek inhibitors and uses thereof
TW202404581A (zh) 2022-05-25 2024-02-01 美商醫肯納腫瘤學公司 Ｍｅｋ抑制劑及其用途
CN115181756B (zh) * 2022-08-03 2023-06-16 四川省医学科学院·四川省人民医院 一种重组慢病毒载体、重组慢病毒质粒、细胞模型及相关应用
WO2024092116A1 (en) 2022-10-26 2024-05-02 Ikena Oncology, Inc. Combination of tead inhibitors and egfr inhibitors and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1187185A (zh) * 1995-06-07 1998-07-08 中国医学科学院药物研究所 查尔酮维甲类化合物及其应用方法
FR2741876B1 (fr) * 1995-12-01 1998-01-09 Cird Galderma Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations
JP2000515506A (ja) * 1996-07-08 2000-11-21 ガルデルマ リサーチ アンド デヴェロップメント エス エヌ シー アポプトーシスを誘発するアダマンチル誘導体及び該誘導体の抗癌剤としての使用
AU3408901A (en) * 2000-02-15 2001-08-27 Teijin Ltd Cancer remedy comprising anthranilic acid derivative as active ingredient
JP4083422B2 (ja) * 2000-12-22 2008-04-30 石原産業株式会社 アニリン誘導体またはその塩ならびにそれらを含有するサイトカイン産生抑制剤
CA2432713C (en) * 2000-12-22 2009-10-27 Ishihara Sangyo Kaisha, Ltd. Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
GB0206215D0 (en) * 2002-03-15 2002-05-01 Novartis Ag Organic compounds
EP1763514A2 (en) * 2004-05-18 2007-03-21 Rigel Pharmaceuticals, Inc. Cycloalkyl substituted pyrimidinediamine compounds and their uses
EP2607348B8 (en) * 2009-03-31 2021-04-21 Renascience Inc. Plasminogen Activator Inhibitor-1 Inhibitor
US8883888B2 (en) * 2009-06-30 2014-11-11 Zeon Corporation Diarylamine compounds, aging inhibitor, polymer composition, crosslinked rubber product and molded article of the crosslinked product, and method of producing diarylamine compound
US20110053916A1 (en) * 2009-08-14 2011-03-03 Vertex Pharmaceuticals Incorporated Pyrimidine compounds as tuberculosis inhibitors
US9249124B2 (en) * 2011-03-30 2016-02-02 H. Lee Moffitt Cancer Center And Research Institute, Inc. Aurora kinase inhibitors and methods of making and using thereof
EP2990057B1 (en) * 2013-04-15 2019-03-20 Renascience Co., Ltd. Pai-1 inhibitor for use in enhancing the antitumor effect of an antitumor agent in a patient
US9963439B2 (en) * 2013-08-20 2018-05-08 University Of Washington Through Its Center For Commercialization Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase
JP6887996B2 (ja) * 2015-09-23 2021-06-16 ザ ジェネラル ホスピタル コーポレイション Ｔｅａｄ転写因子自己パルミトイル化阻害剤
US10772876B2 (en) * 2016-03-17 2020-09-15 Xeniopro GmbH Enhancers of Notch signaling and the use thereof in the treatment of cancers and malignancies medicable by upregulation of Notch
WO2018154118A2 (en) * 2017-02-24 2018-08-30 Reinmueller Viktoria Novel aromatic compounds
CN108530310A (zh) * 2017-03-02 2018-09-14 中国科学院上海药物研究所 2-(取代苯杂基)芳香甲酸类fto抑制剂，其制备方法及其应用
WO2018160138A1 (en) * 2017-03-02 2018-09-07 Aslan Pharmaceuticals Pte Ltd Dhodh inhibitor for treating haematological cancer
JP6978251B2 (ja) * 2017-03-03 2021-12-08 アスラン ファーマシューティカルズ ピーティーイー リミテッド がん治療
EP3661909B1 (en) * 2017-08-02 2023-08-16 Merck Sharp & Dohme LLC Novel substituted phenyl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
US11701364B2 (en) * 2018-02-21 2023-07-18 The Scripps Research Institute Agonists of stimulator of interferon genes sting

Similar Documents

Publication Publication Date Title
JP2023113615A (ja) Ｔｅａｄ転写因子の新規小分子阻害剤
EP2380881B1 (en) Novel bicyclic heterocyclic compound
EP3022202B1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
AU2022200946A1 (en) Modulators of the integrated stress pathway
ES2641478T3 (es) Derivados de 3-acetilamino-1-(fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino)benceno para el tratamiento de trastornos hiperproliferativos
CN111032034B (zh) 螺环化合物及其制造和使用方法
JPWO2020190774A5 (el)
EA026723B1 (ru) Терапевтически активные соединения и способы их применения
EA027120B1 (ru) Противофиброзные пиридиноны
KR20160101065A (ko) Lta4h 억제제로서의 헤테로아릴 부탄산 유도체
EA021543B1 (ru) Сульфонилпиразольные и сульфонилпиразолиновые производные карбоксамидина как антагонисты 5-ht
CA3082735A1 (en) Substituted macrocyclic indole derivatives
JPH02290841A (ja) 新規化合物、その製法及びそれを含む医薬組成物
AU2019387370A1 (en) Pyrrole and pyrazole compounds and methods of use thereof
JP2017512806A (ja) Ｔｎｋｓ１および／またはｔｎｋｓ２の阻害剤としてのアミド置換されたアゾール化合物
WO2019081573A9 (en) Aromatic sulfonamide derivatives for the treatment of ischemic stroke
JP5667934B2 (ja) 新規２環性複素環化合物からなる医薬
WO2020157194A1 (en) 1,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseases
WO2013161980A1 (ja) シクロヘキサンジアミド誘導体及びその医薬用途
WO2022037648A1 (zh) 吡唑硼酸类化合物、包含其的药物组合物及它们的用途
UA121046C2 (uk) Похідні індолу
CN110248925B (zh) 苯基二氟甲基取代脯氨酰胺化合物
EP2784065B1 (en) Glycine reuptake inhibitor and use thereof
CN115974855A (zh) Ezh2和hdac双靶点抑制剂、其药物组合物及其制备方法和用途
BR112021002690A2 (pt) agentes inibidores de ask1